Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Molecular subtype combined with peripheral blast clearance rate to optimize the treatment of newly diagnosed Acute Myeloid Leukemia: Interim analysis of the multicenter, Phase II study (IA+X 2024)

Yunxiang Zhang, Hongming Zhu, Xiangqin Weng, Yongmei Zhu, Jiong Hu, Xiaoxia Hu, Qiusheng Chen, Ligen Liu, Junmin Li, Yang Shen

Blood (2025) 146 (Supplement 1): 3436.

https://doi.org/10.1182/blood-2025-3436

Published: 2025

Journal Articles

Impact of induction response and co-mutations on transplant outcomes in AML with myelodysplasia-related gene mutations: A multicenter retrospective study

Xing Chen, Ruoxuan Zhang, Liang Huang, Xiaodong Mo, Xiaoxia Hu, Yang Cao

Blood (2025) 146 (Supplement 1): 3394.

https://doi.org/10.1182/blood-2025-3394

Published: 2025

Journal Articles

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Zilu Zhang, Xiaoqian Xu, Qi Wen, Ruoxuan Zhang, Hongru Chen, Minli Hu, Chupeng Zhang, Chuanhe Jiang, Luxiang Wang, Jiayu Huang, Zengkai Pan, Hua Jin, Yanmin Zhao, Wei Shi, Xiao-Dong Mo, Yang Cao, Xiaoxia Hu

Blood (2025) 146 (Supplement 1): 1062.

https://doi.org/10.1182/blood-2025-1062

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Novel bispecific epitope anti-CD5 nanobody CAR-T cells for refractory or relapsed T-cell malignancies

Haiyang LU, Su LI, Ang Zhang, Chuanhe Jiang, Jing PAN, Xiaoxia Hu

Blood (2025) 146 (Supplement 1): 5933.

https://doi.org/10.1182/blood-2025-5933

Published: 2025

Journal Articles

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

Ruoxuan Zhang, Yang Cao, Hua Jin, Wei Shi, Xiaoxia Hu, Liang Huang

Blood (2025) 146 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2025-4205

Published: 2025

Journal Articles

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2025-5297

Published: 2025

Journal Articles

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Xiaoxia Hu, Yunxiang Zhang, Jianfeng Li, Jingtao Huang, Shaowei Qiu, Anli Lai, Jia Chen, Xiao-Dong Mo, Huafeng Wang, Yanmin Zhao, Xiaoyu Zhu, Yang Cao, Ran Zhang, Weijie Cao, Yue Lu, Fang Zhou, Xiangqin Weng, Yongmei Zhu

Blood (2025) 146 (Supplement 1): 1698.

https://doi.org/10.1182/blood-2025-1698

Published: 2025

Journal Articles

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Blood (2024) 144 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2024-205561

Published: 2024

Journal Articles

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Chuan Li, Danping Zhu, Jia Chen, Xiaoyu Zhu, Nainong Li, Weijie Cao, Zhongming Zhang, Yehui Tan, Xiaoxia Hu, Hailong Yuan, Xiaosheng Fang, Yue Yin, Hongtao Wang, Nan Li, Xiao Jun Huang, Yuqian Sun

Blood (2024) 144 (Supplement 1): 2133.

https://doi.org/10.1182/blood-2024-202020

Published: 2024

Journal Articles

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Jingtao Huang, Jing Zhou, Shixuan Zhang, Ruoxuan Zhang, Zengkai Pan, Luxiang Wang, Chuanhe Jiang, Jiayu Huang, Zilu Zhang, Yanmin Zhao, Yang Cao, Jianmin Wang, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 268.

https://doi.org/10.1182/blood-2024-202762

Published: 2024

Journal Articles

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Hengwei Wu, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Lizhen Liu, Xiaoyu Lai, Luxin Yang, Yishan Ye, Congxiao Zhang, Weijie Cao, Junjie Cao, Xiaojun Xu, Xiaoxia Hu, Ying Lu, He Huang, Yanmin Zhao

Blood (2024) 144 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2024-206823

Published: 2024

Journal Articles

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Zengkai Pan, Yujun Deng, Jingtao Huang, Aijie Huang, Xiong Ni, Lei Gao, Chuanhe Jiang, Luxiang Wang, Zilu Zhang, Quan Gu, Hui Cheng, Jianmin Wang, Hongbo Hu, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 101.

https://doi.org/10.1182/blood-2024-200811

Published: 2024

Journal Articles

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Yang Cao, Wenxuan Huo, Yang Yang, Jiayu Huang, Yu Wang, Liang Huang, Yingjun Chang, Xiaoxia Hu, Xiaodong Mo

Blood (2023) 142 (Supplement 1): 3620.

https://doi.org/10.1182/blood-2023-185667

Published: 2023

Journal Articles

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

Zengkai Pan, Yujun Deng, Aijie Huang, Zilu Zhang, Luxiang Wang, Hongbo Hu, Jianmin Wang, Xiaoxia Hu

Blood (2022) 140 (Supplement 1): 7636–7637.

https://doi.org/10.1182/blood-2022-165074

Published: 2022

Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Xiaoxia Hu, Aijie Huang, Qi Chen, Ying Zhang, Lixia Liu, Chengcheng Wang, Weiping Zhang, Jianmin Yang, Jianmin Wang

Blood (2019) 134 (Supplement_1): 2713.

https://doi.org/10.1182/blood-2019-129186

Published: 2019

Journal Articles

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Libing Wang, Xiaoxia Hu, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Jianmin Wang, MD

Blood (2013) 122 (21): 1379.

https://doi.org/10.1182/blood.V122.21.1379.1379

Published: 2013

Journal Articles

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Xiaoxia Hu, Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lü, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Jianmin Wang, MD

Blood (2013) 122 (21): 1356.

https://doi.org/10.1182/blood.V122.21.1356.1356

Published: 2013

Journal Articles

Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation

Hui Yu, Hongmei Shen, Youzhong Yuan, Richard XuFeng, Xiaoxia Hu, Sean P. Garrison, Lin Zhang, Jian Yu, Gerard P. Zambetti, Tao Cheng

Blood (2010) 115 (17): 3472–3480.

https://doi.org/10.1182/blood-2009-10-248278

Published: 2010

Includes: Supplemental data

Journal Articles

Hematopoietic Regeneration Is Suppressed by the GvHD Condition in a Haplo-Identical Bone Marrow Transplant Model.

Xiaoxia Hu, M.D., PhD, Xiaomeng Zhuang, M.D., Weiwei Zhang, B.S., Chongmei Huang, M.D., Shenglan Gong, B.S., Hui Cheng, B.S., Tao Cheng, M.D., Jianmin Wang, M.D.

Blood (2009) 114 (22): 1343.

https://doi.org/10.1182/blood.V114.22.1343.1343

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Molecular subtype combined with peripheral blast clearance rate to optimize the treatment of newly diagnosed Acute Myeloid Leukemia: Interim analysis of the multicenter, Phase II study (IA+X 2024)

Impact of induction response and co-mutations on transplant outcomes in AML with myelodysplasia-related gene mutations: A multicenter retrospective study

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Novel bispecific epitope anti-CD5 nanobody CAR-T cells for refractory or relapsed T-cell malignancies

Prognostic impact of transplant conditioning intensity (TCI) score and minimal identifiable disease (MID) in MDS: A multicenter trophy group study

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia with fus::ERG fusion: A national, retrospective, multi-center study

Changing Donor Was Critical for the Successful Salvage Second Transplantation for Graft Failure after the First Allogeneic Stem Cell Transplantation: A Chinese Multicenter Retrospective Study

Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

MRD Positivity Was the Poor Prognostic Factor for Adverse-Risk AML Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Trohpy Study

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation

Hematopoietic Regeneration Is Suppressed by the GvHD Condition in a Haplo-Identical Bone Marrow Transplant Model.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only